| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1953) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | P01BD01 |
| UNII: | Z3614QOX8W |
| InChI Key | WKSAUQYGYAYLPV-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H13ClN4 |
| Molecular Weight | 248.72 |
| AlogP | 2.52 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 77.82 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 17.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | - | - | 51500 | - | |
|
Enzyme
Hydrolase
|
- | 3100-17000 | - | - | - | |
|
Enzyme
Oxidoreductase
|
- | 80-390 | 1-16 | 0-860 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 107 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 13570 | - | 3600 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | - | - | 145 | - | |
|
Unclassified protein
|
- | 2480 | - | 1 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Toxoplasmosis | 4 | D014123 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Pregnancy | 3 | D011247 | ClinicalTrials |
| HIV Infections | 3 | D015658 | ClinicalTrials |
| HIV Infections | 3 | D015658 | ClinicalTrials |
| Pneumonia, Pneumocystis | 3 | D011020 | ClinicalTrials |
| Chorioretinitis | 3 | D002825 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Premature Birth | 3 | D047928 | ClinicalTrials |
| Anemia | 3 | D000740 | ClinicalTrials |
| Toxoplasmosis, Congenital | 3 | D014125 | ClinicalTrials |
| Malaria, Falciparum | 3 | D016778 | ClinicalTrials |
| Malaria, Vivax | 3 | D016780 | ClinicalTrials |
| Schistosomiasis | 3 | D012552 | ClinicalTrials |
| Toxoplasmosis, Cerebral | 2 | D016781 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 1 | D000690 | ClinicalTrials |
| Sandhoff Disease | 1 | D012497 | ClinicalTrials |
| Tay-Sachs Disease | 1 | D013661 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 58-14-0 |
| ChEBI | 8673 |
| ChEMBL | CHEMBL36 |
| DrugBank | DB00205 |
| DrugCentral | 2332 |
| EPA CompTox | DTXSID9021217 |
| FDA SRS | Z3614QOX8W |
| Human Metabolome Database | HMDB0014350 |
| Guide to Pharmacology | 4800 |
| KEGG | C07391 |
| PDB | CP6 |
| PharmGKB | PA451193 |
| PubChem | 4993 |
| SureChEMBL | SCHEMBL25129 |
| ZINC | ZINC000000057464 |